E. coli O111:B4 LPS (Sigma-Aldrich) at a concentration of 15 mg/L was injected into the peritoneal cavity of female BALB/c mice (age 7 weeks, weight 15 ± 0.5 g), and approximately 30 min after the challenge of E. coli O111:B4 LPS, MccJ25 was orally gavaged to the mice at a concentration of 4.55 or 9.1 mg per kg body weight (BW). The concentrations of MccJ25 were selected based on our previous study (24 (link)). Mice were followed for 72 h to test the survival rate of mice that were later sacrificed. However, for LPS treated mice, when the lifespan of the mice was around 50%, the mice were sacrificed. The serum from mice were obtained. The lung, liver, spleen, jejunum, and ileum were harvested, kept in liquid nitrogen immediately, stored at -80°C until analysis. For histopathological assessment, tissues and organs were fixed using 4% paraformaldehyde, hematoxylin eosin (H&E) was applied to examine the histological and pathological changes according to the standard protocol as described previously (24 (link)).
Lps e coli o111 b4
LPS (E. coli O111:B4) is a laboratory reagent produced by Merck Group. It is a lipopolysaccharide extracted from the cell wall of Escherichia coli O111:B4 bacteria. This product is commonly used in research applications that require a source of endotoxin for in vitro studies.
Lab products found in correlation
94 protocols using lps e coli o111 b4
Alleviation of LPS-Induced Sepsis in Mice
E. coli O111:B4 LPS (Sigma-Aldrich) at a concentration of 15 mg/L was injected into the peritoneal cavity of female BALB/c mice (age 7 weeks, weight 15 ± 0.5 g), and approximately 30 min after the challenge of E. coli O111:B4 LPS, MccJ25 was orally gavaged to the mice at a concentration of 4.55 or 9.1 mg per kg body weight (BW). The concentrations of MccJ25 were selected based on our previous study (24 (link)). Mice were followed for 72 h to test the survival rate of mice that were later sacrificed. However, for LPS treated mice, when the lifespan of the mice was around 50%, the mice were sacrificed. The serum from mice were obtained. The lung, liver, spleen, jejunum, and ileum were harvested, kept in liquid nitrogen immediately, stored at -80°C until analysis. For histopathological assessment, tissues and organs were fixed using 4% paraformaldehyde, hematoxylin eosin (H&E) was applied to examine the histological and pathological changes according to the standard protocol as described previously (24 (link)).
Simulating Innate Immune Responses
Profiling Oxidative Stress Markers
LPS Stimulation of Cell Cultures
Intestinal Inflammation Modulation by Peptides
The mice were randomly distributed into six groups (n = 12 each): control, LPS (E. coli, O111:B4, Sigma-Aldrich, USA) treatment, LL-37 pretreatment followed by LPS treatment (LL-37 + LPS), Tα1 pretreatment followed by LPS treatment (Tα1 + LPS), LTA pretreatment followed by LPS treatment (LTA + LPS). Different peptides (10 mg/kg mouse weight) were injected intraperitoneally once daily for 7 days, whereas an equal volume of sterile saline was injected intraperitoneally to the control and LPS-treated groups. On day 7, mice in LPS, LL-37 + LPS, Tα1 + LPS, and LTA + LPS groups were intraperitoneally injected with LPS (10 mg/kg mouse weight) 1h after saline or the peptides treatment, and the control group was intraperitoneally injected with an equal volume of saline. The mice were then euthanized by cervical dislocation 6 h after intraperitoneal injection of LPS or saline, and samples of the intestines were collected for analysis. The body weights of the mice were recorded before and after the experiment.
Human and Rat Cell Culture Protocols
Differentiation and LPS Treatment of PC12 Cells
LPS and TAK 242 Preparation Protocol
In vitro microglial cell study
Inflammatory Pathway Activation Assays
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!